This article presents a 16-year follow-up of the European Randomized Study of Screening for Prostate Cancer, which evaluates the long-term outcomes of prostate cancer screening using PSA testing. The study found that screening led to a modest reduction in prostate cancer mortality, but with a higher risk of overdiagnosis and
